Journal profile · Medicine-Urology
Prostate International
ISSN 2287-8882 · eISSN 2287-903X · Elsevier · SOUTH KOREA
Prostate International: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.93; fully open access; APC about USD 1,800; median 51 days to acceptance (78 articles, last 24 months); 43 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Prostate International is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research and Urinary Bladder and Prostate Research, together about 63.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Prostate International, the Official Journal of Asian Pacific Prostate Society (APPS) and Korean Prostate Society (KPS), is an international peer-reviewed academic journal dedicated to basic and clinical studies on prostate cancer, benign prostatic hyperplasia, prostatitis, and other prostatic diseases. Its formal abbreviation is Prostate Int. Original articles and topical reviews on various prostate-related conditions and problems are published in Prostate International, covering the state-of-the-art contents. Analysis articles, Technical reports, and invited/commissioned meeting reports are also published in Prostate International. Prostate International represents the only academic journal devoted to various prostatic diseases in the Asian Pacific region. The incidence, characteristics, and management of various diseases may vary according to region and race. Prostate International brings solid coverage of prostatic diseases in Asian Pacific men. Prostate International also serves as a medium for cooperation amongst urologists and specialists from around the world focusing on various aforementioned prostatic conditions. All or part of Prostate International is indexed/tracked/covered by DOI/Crossref, Google Scholar, ScienceCentral and PubMed.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Urology
Editor-in-chief Sung Kyu HongPublisher website
Editorial board by country: none in mainland China; most named South Korea 24, Japan 10, United States 8, Taiwan, China 2, United Kingdom 2 (56 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Prostate Cancer Diagnosis and TreatmentMedicine31.5%
- Prostate Cancer Treatment and ResearchMedicine21.8%
- Urinary Bladder and Prostate ResearchMedicine10.2%
- Urologic and reproductive health conditionsMedicine4.2%
- Urinary Tract Infections ManagementMedicine3.6%
- Advanced Radiotherapy TechniquesPhysics and Astronomy3.3%
- Sexual function and dysfunction studiesMedicine2.7%
- Pelvic floor disorders treatmentsMedicine2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Andrology | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Urology & Nephrology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Google Scholar, Crossref, DOI/Crossref, ScienceCentral, ScienceDirect
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.93LetPub ·
- Impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher)
- 5.1Publisher website ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 1.35LetPub ·
- h-index
- 36OpenAlex ·
- i10-index
- 208OpenAlex ·
- 2-year mean citedness
- 2.35OpenAlex ·
- Self-citation rate
- 22.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 41LetPub ·
Articles by year OpenAlex count · 508 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 47 | 47 | 6 |
| 2025 | 43 | 43 | 99 |
| 2024 | 46 | 46 | 214 |
| 2023 | 29 | 29 | 387 |
| 2022 | 44 | 44 | 496 |
| 2021 | 26 | 26 | 334 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
51 daysMedian, submission to acceptance · P25–P75 36 days – 80 days
- Acceptance to online
- median 6 days (78 articles)
- Submission to online
- median 57 days
- Sample
- 78 articles with submission and acceptance dates (90 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 18 daysPublisher website ·
- Submission to acceptance
- 54 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 34 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,800 | Yes | CC BY-NC-ND | |
| OpenAlex | USD 1,800 / EUR 1,680 / GBP 1,440 / JPY 223,250 | — | — | |
| LetPub | USD 1,800 | Yes | — |
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 300 words
- Manuscript length
- ≤ 3,000 words
- Reference style
- Vancouver
Article types accepted4
- editorial1. Review articleReview articles shall be limited to an invited review article, which, by the Editorial Board, was selected as a significant theme from areas re…Length not stated
- original article1. Review articleReview articles shall be limited to an invited review article, which, by the Editorial Board, was selected as a significant theme from areas re…Length not stated
- review1. Review articleReview articles shall be limited to an invited review article, which, by the Editorial Board, was selected as a significant theme from areas re…Length not stated
- review article1. Review articleReview articles shall be limited to an invited review article, which, by the Editorial Board, was selected as a significant theme from areas re…Length not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. Conflict of interest statements will be published at the end of…
Source ↗Publisher website ·- License & copyright Copyright
Published manuscripts become the permanent property of Asian Pacific Prostate Society and must not be published elsewhere without written permission. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No part of this publication may be reproduced, stored in any retrieval system,…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a double anonymized review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themse…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- SOUTH KOREA
- Language
- English
- ISSN
- 2287-8882
- Electronic ISSN
- 2287-903X
- Society / sponsor
- Asian Pacific Prostate Society
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Prostate International
What CAS zone is Prostate International in?
In the 2025 upgraded edition of the CAS Journal Ranking, Prostate International is in Zone 3 of Medicine, and in Zone 3 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Prostate International?
The latest impact factor listed by LetPub is 3.93; CiteScore 5.1, h-index 36.
How long does peer review take at Prostate International?
Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 51 days (interquartile range 36–80 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Prostate International?
According to the journal's author guidelines: Abstract: ≤ 300 words; Manuscript length: ≤ 3,000 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Prostate International based?
Of the 56 board members whose country the journal's board page names, none are in mainland China; the countries named most often are South Korea (24), Japan (10) and United States (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Prostate International?
According to LetPub and DOAJ records, Prostate International is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Prostate International open access, and what is the APC?
Prostate International is a fully open-access journal. APC about USD 1,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .